To demonstrate this prediction, we constructed ZFAND2A overexpression cell lines by transfecting CRC cells (HT29 and HCT116) with a ZFAND2A plasmid vector or negative control vector. The gene discussed is ZFAND2A; the disease is colorectal carcinoma.